Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

News Focus

LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Bullboard - Stock Discussion Forum Satellos Bioscience Inc T.MSCL

Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this... see more

Add To Watchlist

Bullboard (TSX:MSCL)

View:

Post by Drambueyon Nov 21, 2023 4:51pm

15,000 gets you……..

Up 23% back to the price which the stock was trading at when they hired ICP Securities Inc. Christmas bonuses all around lol

159

Post by Drambueyon Nov 01, 2023 4:55pm

What does $7,500 a month get you

Stock price down 23% since signing ICP Securities marketing services.

183

Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million

posted Nov 21, 2024 9:00am by Innocan Pharma Corp

"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more

Post by nozzpackon Aug 02, 2023 7:52am

Substantive News....Receives Orphan Drug Status !

ORIGINAL: Satellos Bioscience Receives Orphan Drug Designation from the U.S. FDA for SAT-3153, a First-in-Class Small Molecule Therapeutic for Duchenne Muscular Dystrophy Company also ...more

264

Comment by london6erson Aug 01, 2023 4:29pm

RE:RE:RE:Ranked #1

Yes plus many other applications.

127

Discussion

Post by london6erson Jul 25, 2023 1:13pm

🤔

How can you replace fatty tissue with healthy muscle cells?

177

Comment by london6erson Jul 25, 2023 12:53pm

RE:RE:RE:Ranked #1

I agree but lots of the muscle is filled by scar tissue. What does this do? Replace scar tissue with functioning muscle cells? That's crazy if true..

125

Discussion

Comment by nozzpackon May 23, 2023 1:41pm

RE:RE:Ranked #1

This will be a 25 bagger if that small molecule drug with the potential to regenerate functional muscle is successful as it will have many advantages and benefits for patients muscular ...more

310

Discussion

Post by PressReleaseon May 17, 2023 5:29pm

New Press Release - Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.

Toronto, Ontario--(Newsfile Corp. - May 17, 2023) - Bloom Burton & Co. Inc. announces that, today, it and its affiliate acquired 1,453,070 common shares (Shares) and 6,636,734 compensation options (Compensation Options) of Satellos Bioscience Inc. (Corporation) in connection with a public...read article.

Post by G1945Von May 17, 2023 9:43am

Satellos closes $55M Financing

Satellos Bioscience Closes $55M Financing to Support Development of its Lead Drug Candidate for Duchenne Muscular Dystrophy G1945V

203

Post by PressReleaseon Apr 19, 2023 10:46am

New Press Release - IIROC Trading Resumption - MSCL

VANCOUVER, BC, April 19, 2023 /CNW/ - Trading resumes in:Company: Satellos Bioscience Inc.TSX-Venture Symbol: MSCLAll Issues: YesResumption (ET): 11:00 AMIIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are...read article.

Post by PressReleaseon Apr 19, 2023 10:26am

New Press Release - Satellos Bioscience Inc. Announces Pricing of Public Offering

Toronto, Ontario--(Newsfile Corp. - April 19, 2023) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine company aimed at developing therapeutics that change the way degenerative muscle diseases are treated, is pleased to announce the pricing and terms of...read article.

Post by PressReleaseon Apr 19, 2023 9:29am

New Press Release - IIROC Trading Halt - MSCL

VANCOUVER, BC, April 19, 2023 /CNW/ - The following issues have been halted by IIROC:Company: Satellos Bioscience Inc.TSX-Venture Symbol: MSCLAll Issues: YesReason: Pending NewsHalt Time (ET): 9:17 AMIIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a...read article.

Post by PressReleaseon Apr 18, 2023 5:18pm

New Press Release - Satellos Bioscience Inc. Announces Public Offering of Common Shares

Toronto, Ontario--(Newsfile Corp. - April 18, 2023) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine company aimed at developing therapeutics that change the way degenerative muscle diseases are treated, announced today that it has filed a preliminary...read article.

Post by PressReleaseon Mar 30, 2023 9:57pm

New Press Release - Satellos Bioscience Announces 2022 Year End Financial Results and Operational Highlights

Toronto, Ontario--(Newsfile Corp. - March 30, 2023) - Satellos Bioscience Inc. (TSXV: MSCL) (OTCQB: MSCLF) ("Satellos" or the "Company"), a drug discovery company developing small molecule therapeutics to regenerate muscle as a new approach to treating disease conditions from muscular dystrophy...read article.

Comment by Flatlander05on Mar 30, 2023 4:11pm

RE:RE:Ranked #1

100%

124

Discussion

The Market Update

{{currentVideo.title}} {{currentVideo.relativeTime}}

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}

{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}

{{currentVideo.headline}}

{{currentVideo.link1Text}}

{{currentVideo.link2Text}}

< Previous

{{moreVideoText}}

Next >

Dealroom for high-potential pre-IPO opportunities

Featured News Links

Discover Options Trading Strategies to Minimize your Tax Burden